Avanos Medical (AVNS) Other financing activities (2013 - 2026)

Avanos Medical has disclosed Other financing activities across 14 years of filings, most recently posting $400000.0 for Q1 2026.

• In Q1 2026, Other financing activities changed 0.0% year-over-year to $400000.0; the TTM figure through Mar 2026 stood at $700000.0 (down 30.0% YoY), while the FY2025 annual figure was $700000.0, down 36.36% from the prior year.
• Other financing activities came in at $400000.0 for Q1 2026 at Avanos Medical, up from $300000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $900000.0 in Q3 2023 to a low of -$200000.0 in Q4 2023.
• Average Other financing activities over 5 years is $433333.3, with a median of $450000.0 recorded in 2024.
• The largest YoY upside for Other financing activities was 12.5% in 2023 against a maximum downside of 300.0% in 2023.
• Over 5 years, Other financing activities stood at $100000.0 in 2022, then plunged by 300.0% to -$200000.0 in 2023, then jumped by 400.0% to $600000.0 in 2024, then plunged by 50.0% to $300000.0 in 2025, then surged by 33.33% to $400000.0 in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $400000.0 in Q1 2026, $300000.0 in Q3 2025, and $400000.0 in Q1 2025.